Cargando…
Potential of Novel EPO Derivatives in Limb Ischemia
Erythropoietin (EPO) has tissue-protective properties, but it increases the risk of thromboembolism by raising the haemoglobin concentration. New generation of EPO derivatives is tissue protective without the haematopoietic side effects. Preclinical studies have demonstrated their effectiveness and...
Autores principales: | Joshi, Dhiraj, Tsui, Janice, Yu, Rebekah, Shiwen, Xu, Selvakumar, Sadasivam, Abraham, David J., Baker, Daryll M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296231/ https://www.ncbi.nlm.nih.gov/pubmed/22462027 http://dx.doi.org/10.1155/2012/213785 |
Ejemplares similares
-
Nitric Oxide Manipulation: A Therapeutic Target for Peripheral Arterial Disease?
por: Williams, Gareth, et al.
Publicado: (2012) -
Toll-Like Receptors in Ischaemia and Its Potential Role in the Pathophysiology of Muscle Damage in Critical Limb Ischaemia
por: Patel, Hemanshu, et al.
Publicado: (2012) -
Cell Signalling Pathways Leading to Novel Therapeutic Strategies in Cardiovascular Disease
por: Shaw, Sidney G., et al.
Publicado: (2012) -
ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injury
por: van Rijt, Willem G, et al.
Publicado: (2013) -
Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021)